Evaluation of TRIzol LS inactivation of viruses

Tadeusz J. Kochel, Gregory A. Kocher, Thomas Ksiazek, James P. Burans

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Prior to the release from BSL-3 or -4 laboratories, materials from which nucleic acids are to be extracted must be renderednoninfectious. Typically, phenol/guanidine thiocyanate reagents such as TRIzol LS have been used to extract and inactivate RNAfrom infectious viruses. Because of the toxicity of this reagent to the tissue culture cells used to propagate viruses, it has beendifficult to fully evaluate the sterility of extracted viral RNA using tissue culture. In this study, we have demonstrated the use ofsucrose cushion centrifugation to remove TRIzol LS from extracted viral suspensions. The inactivated viral suspensions were thensterility tested without confounding cell toxicity from TRIzol LS. This method allowed a clear demonstration of the use of TRIzolLS to inactivate a broad group of viral families that include Togaviridae, Arenaviridae, Bunyaviridae, Coronaviridae, Filoviridae,Flaviviridae, and Paramyxoviridae at titers ranging from a high of 106.1 to 108.3 tissue culture infectious dose 50% (TCID50/mL) to thelower limit of virus detection in cell culture. TRIzol LS used in a ratio of 4 parts TRIzol LS to 1 part viral suspension inactivatedrepresentative viruses of all families tested.

Original languageEnglish (US)
Pages (from-to)52-55
Number of pages4
JournalApplied Biosafety
Volume22
Issue number2
DOIs
StatePublished - Jun 1 2017

Fingerprint

Virus Inactivation
virus
Viruses
Suspensions
Filoviridae
Arenaviridae
Coronaviridae
toxicity
Togaviridae
Paramyxoviridae
Cell Culture Techniques
sterility
Bunyaviridae
Flaviviridae
nucleic acid
Viral RNA
RNA
phenol
Phenol
Centrifugation

Keywords

  • BSL-4
  • Infectious agent
  • Operating procedure
  • Pathogen
  • Standard
  • Sterilization

ASJC Scopus subject areas

  • Biotechnology
  • Public Health, Environmental and Occupational Health
  • Health, Toxicology and Mutagenesis
  • Management, Monitoring, Policy and Law

Cite this

Evaluation of TRIzol LS inactivation of viruses. / Kochel, Tadeusz J.; Kocher, Gregory A.; Ksiazek, Thomas; Burans, James P.

In: Applied Biosafety, Vol. 22, No. 2, 01.06.2017, p. 52-55.

Research output: Contribution to journalArticle

Kochel, Tadeusz J. ; Kocher, Gregory A. ; Ksiazek, Thomas ; Burans, James P. / Evaluation of TRIzol LS inactivation of viruses. In: Applied Biosafety. 2017 ; Vol. 22, No. 2. pp. 52-55.
@article{8f3c950442a84308aad7fa0ced3b64aa,
title = "Evaluation of TRIzol LS inactivation of viruses",
abstract = "Prior to the release from BSL-3 or -4 laboratories, materials from which nucleic acids are to be extracted must be renderednoninfectious. Typically, phenol/guanidine thiocyanate reagents such as TRIzol LS have been used to extract and inactivate RNAfrom infectious viruses. Because of the toxicity of this reagent to the tissue culture cells used to propagate viruses, it has beendifficult to fully evaluate the sterility of extracted viral RNA using tissue culture. In this study, we have demonstrated the use ofsucrose cushion centrifugation to remove TRIzol LS from extracted viral suspensions. The inactivated viral suspensions were thensterility tested without confounding cell toxicity from TRIzol LS. This method allowed a clear demonstration of the use of TRIzolLS to inactivate a broad group of viral families that include Togaviridae, Arenaviridae, Bunyaviridae, Coronaviridae, Filoviridae,Flaviviridae, and Paramyxoviridae at titers ranging from a high of 106.1 to 108.3 tissue culture infectious dose 50{\%} (TCID50/mL) to thelower limit of virus detection in cell culture. TRIzol LS used in a ratio of 4 parts TRIzol LS to 1 part viral suspension inactivatedrepresentative viruses of all families tested.",
keywords = "BSL-4, Infectious agent, Operating procedure, Pathogen, Standard, Sterilization",
author = "Kochel, {Tadeusz J.} and Kocher, {Gregory A.} and Thomas Ksiazek and Burans, {James P.}",
year = "2017",
month = "6",
day = "1",
doi = "10.1177/1535676017713739",
language = "English (US)",
volume = "22",
pages = "52--55",
journal = "Applied Biosafety",
issn = "1535-6760",
publisher = "SAGE Publications Inc.",
number = "2",

}

TY - JOUR

T1 - Evaluation of TRIzol LS inactivation of viruses

AU - Kochel, Tadeusz J.

AU - Kocher, Gregory A.

AU - Ksiazek, Thomas

AU - Burans, James P.

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Prior to the release from BSL-3 or -4 laboratories, materials from which nucleic acids are to be extracted must be renderednoninfectious. Typically, phenol/guanidine thiocyanate reagents such as TRIzol LS have been used to extract and inactivate RNAfrom infectious viruses. Because of the toxicity of this reagent to the tissue culture cells used to propagate viruses, it has beendifficult to fully evaluate the sterility of extracted viral RNA using tissue culture. In this study, we have demonstrated the use ofsucrose cushion centrifugation to remove TRIzol LS from extracted viral suspensions. The inactivated viral suspensions were thensterility tested without confounding cell toxicity from TRIzol LS. This method allowed a clear demonstration of the use of TRIzolLS to inactivate a broad group of viral families that include Togaviridae, Arenaviridae, Bunyaviridae, Coronaviridae, Filoviridae,Flaviviridae, and Paramyxoviridae at titers ranging from a high of 106.1 to 108.3 tissue culture infectious dose 50% (TCID50/mL) to thelower limit of virus detection in cell culture. TRIzol LS used in a ratio of 4 parts TRIzol LS to 1 part viral suspension inactivatedrepresentative viruses of all families tested.

AB - Prior to the release from BSL-3 or -4 laboratories, materials from which nucleic acids are to be extracted must be renderednoninfectious. Typically, phenol/guanidine thiocyanate reagents such as TRIzol LS have been used to extract and inactivate RNAfrom infectious viruses. Because of the toxicity of this reagent to the tissue culture cells used to propagate viruses, it has beendifficult to fully evaluate the sterility of extracted viral RNA using tissue culture. In this study, we have demonstrated the use ofsucrose cushion centrifugation to remove TRIzol LS from extracted viral suspensions. The inactivated viral suspensions were thensterility tested without confounding cell toxicity from TRIzol LS. This method allowed a clear demonstration of the use of TRIzolLS to inactivate a broad group of viral families that include Togaviridae, Arenaviridae, Bunyaviridae, Coronaviridae, Filoviridae,Flaviviridae, and Paramyxoviridae at titers ranging from a high of 106.1 to 108.3 tissue culture infectious dose 50% (TCID50/mL) to thelower limit of virus detection in cell culture. TRIzol LS used in a ratio of 4 parts TRIzol LS to 1 part viral suspension inactivatedrepresentative viruses of all families tested.

KW - BSL-4

KW - Infectious agent

KW - Operating procedure

KW - Pathogen

KW - Standard

KW - Sterilization

UR - http://www.scopus.com/inward/record.url?scp=85021362480&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021362480&partnerID=8YFLogxK

U2 - 10.1177/1535676017713739

DO - 10.1177/1535676017713739

M3 - Article

AN - SCOPUS:85021362480

VL - 22

SP - 52

EP - 55

JO - Applied Biosafety

JF - Applied Biosafety

SN - 1535-6760

IS - 2

ER -